Back
Evolve Enhanced Yield Bond Fund Vs. MiNK Therapeutics, Inc. Industry Stock Comparison
Sell
34
BOND.TO
Evolve Enhanced Yield Bond Fund
Last Price:
$17.44
Seasonality Move:
-3.05%
Sell
27
INKT
MiNK Therapeutics, Inc.
Last Price:
$11.68
Seasonality Move:
-18.07%
Sell
34
Evolve Enhanced Yield Bond Fund (BOND.TO)
is a Sell
Is Evolve Enhanced Yield Bond Fund a Buy, Sell or Hold?
-
The current Evolve Enhanced Yield Bond Fund [BOND.TO] share price is $17.44. The Score for BOND.TO is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
BOND.TO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
MiNK Therapeutics, Inc. (INKT)
is a Sell
Is MiNK Therapeutics, Inc. a Buy, Sell or Hold?
-
The current MiNK Therapeutics, Inc. [INKT] share price is $11.59. The Score for INKT is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
-
INKT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BOND.TO Stock Price Chart
What is Evolve Enhanced Yield Bond Fund's stock price today?
-
The Evolve Enhanced Yield Bond Fund share price today is $17.44The current trend is relatively stagnant and BOND.TO is experiencing slight selling pressure.
INKT Stock Price Chart
What is MiNK Therapeutics, Inc.'s stock price today?
-
The MiNK Therapeutics, Inc. share price today is $11.59Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INKT is experiencing slight buying pressure.
BOND.TO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.12 | Sell |
| Relative Strength Index (14 RSI): | 39.42 | Sell |
| Chaikin Money Flow: | -28680 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.42 - 17.82) | Sell |
| Bollinger Bands (100): | (17.63 - 18.11) | Sell |
INKT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.19 | Sell |
| Relative Strength Index (14 RSI): | 44.79 | Sell |
| Chaikin Money Flow: | 9780 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
BOND.TO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.43 | Buy |
| 20-day SMA: | 17.59 | Sell |
| 50-day SMA: | 17.84 | Sell |
| 200-day SMA: | 17.99 | Sell |
| 8-day EMA: | 17.45 | Sell |
| 20-day EMA: | 17.55 | Sell |
| 50-day EMA: | 17.72 | Sell |
| 200-day EMA: | 18.13 | Sell |
INKT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.09 | Sell |
| 20-day SMA: | 11.62 | Sell |
| 50-day SMA: | 12.8 | Sell |
| 200-day SMA: | 11.89 | Sell |
| 8-day EMA: | 11.86 | Sell |
| 20-day EMA: | 11.96 | Sell |
| 50-day EMA: | 12.6 | Sell |
| 200-day EMA: | 12.22 | Sell |
Evolve Enhanced Yield Bond Fund Earnings Growth & BOND.TO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
MiNK Therapeutics, Inc. Earnings Growth & INKT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.82 per share.
Evolve Enhanced Yield Bond Fund Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
MiNK Therapeutics, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||